CGTN BizTalk Promo: BioNTech CEO: mRNA tech and the future of vaccine development

German company BioNTech jointly developed the now widely-used Pfizer/BioNTech COVID-19 vaccine using mRNA technology, which was originally optimized for the development of cancer vaccines. Learn more about the couple who founded BioNTech and the stories behind the successes of the company, both in terms of its business and science.

This Saturday, CGTN BizTalk's Lily Lyu speaks to Dr. Ugur Sahin, CEO and co-founder of BioNTech and he talks about mRNA technology and his vision for the future of vaccine development.

Search Trends